Back to Journals » OncoTargets and Therapy » Volume 9

Original Research

Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis

       
Total article views   HTML views PDF downloads Totals
7,003 Dovepress* 6,292+ 916 7,208
PubMed Central* 711 171 882
Totals 7,003 1,087 8,090
*Since 4 November 2016

View citations on PubMed Central and Google Scholar